Granulocyte Colony-Stimulating Factor is Safe and Well Tolerated following Allogeneic Transplantation in Patients with Sickle Cell Disease. Transplant Cell Ther. 2021.
Length of Stay and Health Care Utilization Among Pediatric Autologous Hematopoietic Cell Transplantation Recipients. Transplant Cell Ther. 2021.
Hematopoietic stem cell transplantation and cellular therapy in sickle cell disease: where are we now?. Curr Opin Hematol. 2019..
Hematopoietic stem cell transplantation for CD40 ligand deficiency: results from an EBMT/ESID-IEWP-SCETIDE-PIDTC Study. J Allergy Clin Immunol. 2019.
Improved Splenic Function After Hematopoietic Stem Cell Transplant for Sickle Cell Disease. Pediatr Blood Cancer. 2016..
The Efficacy of Tacrolimus/Mycophenolate Mofetil as Acute Graft-Versus-Host-Disease Prophylaxis and the Impact of Sub Therapeutic Tacrolimus Levels in Children Following Matched Sibling Donor Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2014.